{"id":"W4395663602","doi":"10.1158/2767-9764.crc-23-0459","title":"First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston Health Sciences Centre","funders":"Merck KGaA; Pfizer","keywords":"Javelin; Avelumab; Chemotherapy; Medicine; Solid tumor; Oncology; Internal medicine; Cancer; Immunotherapy; Pembrolizumab; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001624352,0.0002914885,0.0004630165,0.0002380895,0.0007486682,0.0001352077,0.001350028,0.00009770129,0.000345199],"category_scores_gemma":[0.0002029046,0.0001936337,0.000111703,0.001792478,0.0006526016,0.0002054106,0.0003041429,0.001264464,0.00002159651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001204205,"about_ca_system_score_gemma":0.001186482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005475398,"about_ca_topic_score_gemma":0.008188788,"domain_scores_codex":[0.9966726,0.0004035322,0.0007186824,0.0006221544,0.001008317,0.0005746647],"domain_scores_gemma":[0.9949878,0.00104828,0.0001144694,0.003169541,0.0005271283,0.0001527165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1309828,0.01857197,0.01845906,0.0002220117,0.003325581,0.0000700007,0.1035829,0.0003399131,0.003886524,0.0001473892,0.03378359,0.6866282],"study_design_scores_gemma":[0.2138034,0.01301537,0.2690086,0.007606368,0.0002028026,0.000007434064,0.01009562,0.01251655,0.002925504,0.0005391414,0.4690335,0.001245763],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9297812,0.01527088,0.00003737511,0.04961557,0.000119622,0.003994785,0.0005561113,0.0001316342,0.0004928254],"genre_scores_gemma":[0.9784301,0.01778366,0.0003741957,0.0008780129,0.0001725662,0.001268399,0.0004155276,0.00009250629,0.0005850301],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6853825,"threshold_uncertainty_score":0.8277201,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08169363019912536,"score_gpt":0.4397402393431038,"score_spread":0.3580466091439785,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}